Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...
David Jilbert's devastating diagnosis of Parkinson's disease three years ago changed his life irrevocably -- and it's a ...
While celebrities like Michael J. Fox and Brett Favre have been open about their struggles with Parkinson's disease, it can ...
The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...
The 25th Light of Day WinferFest main event, aka Bob's Birthday Bash, is Saturday, Jan. 18, at the Count Basie Center for the ...
A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...
Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...
First subjects dosed in a Phase 2 trial of VTX3232 in participants with obesity and cardiometabolic risk factors, with topline data expected in ...
Chronos-PD’ is looking for biological signals that could indicate increased chance of developing Parkinson’s disease (PD) years before symptoms ...
Sleep disturbances encompass a broad range of disorders, such as insomnia, restless legs syndrome, parasomnias, sleep-disordered breathing, daytime ...
Bemdaneprocel will be studied in a sham-surgery controlled, double-blind trial that is expected to start in the first half of ...
Learn how caffeine affects Parkinson's disease prevention and treatment. New research uncovers both protective benefits and treatment limitations.